Englewood Cliffs, NJ, United States of America

Jingyue Ju

This inventor holds 101 USPTO granted patents and 34 published patent applications, plus 2 CIPO patents and 18 EPO patents, primarily in DNA Sequencing (CPC class C12Q1-6869). Top assignees: Columbia University, University of California, Incyte Pharmaceuticals, Inc.. Active years: 1997-2026.

USPTO Granted Patents = 101 (Patent Applications = 34)

% Patents Active = 70.3

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 18 (Patent Applications = 33)

Average Co-Inventor Count = 3.7

ph-index = 36

Forward Citations = 4,665(Granted Patents)

Forward Citations (Not Self Cited) = 2,655(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Berkeley, CA (US) (1997 - 2001)
Redwood City, CA (US) (1998 - 2006)
New York, NY (US) (2020 - 2023)
Englewood Cliffs, NJ (US) (2003 - 2024)

Company Filing History:

University of California

patents

5 out of 576

Incyte Pharmaceuticals, Inc.

patents

4. 4 out of 299

Roche Sequencing Solutions, Inc.

patents

5. 2 out of 761

Government of the United States of America, as Represented by the Secretary of Commerce

patents

6. 1 out of 62

Genia Technologies, Inc.

patents

where one patent can have more than one assignee

Years Active: 1997-2026

Loading Chart...

Areas of Expertise:

DNA Sequencing

Nanopore Detection

Cleavable Nucleotides

Single-Molecule Assays

Nucleotide Derivatives

Fluorescent Labels

Biomarker Detection

Raman Detection

Synthesis Methods

Electronic Multiplexing

Chemical Methods

Massive Parallel Decoding

101 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12559797 - FOUR-COLOR DNA SEQUENCING BY SYNTHESIS USING CLEAVABLE FLUORESCENT NUCLEOTIDE REVERSIBLE TERMINATORS (2026-02-24),

2. 12559796 - Fluorescence energy transfer-based single molecule/ensemble DNA sequencing by synthesis (2026-02-24),

3. 12535477 - Single-molecule electronic multiplex nanopore immunoassays for biomarker detection (2026-01-27),

4. 12503730 - DETECTABLE NUCLEOTIDE ANALOGUES (2025-12-23),

5. 12467085 - High accuracy nanopore-based single molecule sequencing by synthesis with tagged nucleotides (2025-11-11),

6. 12337009 - Nucleotide derivatives and methods of use thereof (2025-06-24),

7. 12331352 - DNA sequencing with non-fluorescent nucleotide reversible terminators and cleavable label modified nucleotide terminators (2025-06-17),

8. 12188086 - Nucleotide analogues and use thereof for nucleic acid sequencing and analysis preliminary class (2025-01-07),

9. 12180544 - Synthesis of cleavable fluorescent nucleotides as reversible terminators for DNA sequencing by synthesis (2024-12-31),

10. 12173366 - DNA sequencing by synthesis using modified nucleotides and nanopore detection (2024-12-24),

11. 12018325 - 3'-O-modified nucleotide analogues with different cleavable linkers for attaching fluorescent labels to the base for DNA sequencing by synthesis (2024-06-25),

12. 12006540 - Synthesis of novel disulfide linker based nucleotides as reversible terminators for DNA sequencing by synthesis (2024-06-11),

13. 11999999 - Synthesis of novel disulfide linker based nucleotides as reversible terminators for DNA sequencing by synthesis (2024-06-04),

14. 11959137 - Synthesis of novel disulfide linker based nucleotides as reversible terminators for DNA sequencing by synthesis (2024-04-16),

15. 11939631 - Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators (2024-03-26),

Title: Innovator Spotlight: Jingyue Ju - Revolutionizing DNA Sequencing Technology

Introduction:

Jingyue Ju, a prolific inventor based in Englewood Cliffs, NJ, has made significant contributions to the field of DNA sequencing technology. With an impressive portfolio of 75 patents, Jingyue Ju continues to drive innovation in this crucial area of scientific research.

Latest Patents:

Jingyue Ju's recent patents showcase his expertise in developing cutting-edge technologies for DNA sequencing. His inventions include 3'-O-modified nucleotide analogues with cleavable linkers for DNA sequencing by synthesis, as well as novel disulfide linker-based nucleotides as reversible terminators. These advancements have the potential to revolutionize the way DNA sequencing is conducted, making it faster, more accurate, and more cost-effective.

Career Highlights:

During his career, Jingyue Ju has lent his expertise to prestigious institutions and companies, including Columbia University in the City of New York and Roche Sequencing Solutions, Inc. His innovative work has not only earned him numerous patents but has also positioned him as a leading figure in the field of DNA sequencing technology.

Collaborations:

Collaboration is at the heart of scientific innovation, and Jingyue Ju has had the privilege of working alongside talented individuals such as Zengmin Li and John Robert Edwards. These collaborations have led to the development of groundbreaking technologies that are shaping the future of DNA sequencing.

Conclusion:

In conclusion, Jingyue Ju's contributions to DNA sequencing technology have been nothing short of remarkable. His relentless pursuit of innovation and his dedication to pushing the boundaries of scientific research continue to inspire and drive progress in this field. Jingyue Ju stands as a testament to the power of innovative thinking and collaboration in shaping the future of biotechnology.